Cargando…

Decreasing susceptibility of bacteria to ampicillin/ sulbactam and third generation cephalosporins in urinary tract infections

BACKGROUND: Urinary tract infections (UTIs) are among the most common bacterial infections worldwide and have become more difficult to treat over the years. Inappropriate antibiotic use has led to increased antibiotic resistance. MATERIALS AND METHODS: We examined 1921 urine culture samples from a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallo, Stefan, Wirth, Patrick, Kukic, Adnan, Nafez, Omar, Neagoe, Ladislau, Nestler, Sebastian, Jones, Jon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782476/ https://www.ncbi.nlm.nih.gov/pubmed/36601280 http://dx.doi.org/10.1097/CU9.0000000000000079

Ejemplares similares

Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock
por: Kounis, Nicholas G., et al.
Publicado: (2017)

Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease
por: Jemsek, Joseph G., et al.
Publicado: (1997)

Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)

Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients
por: Setiawan, Eko, et al.
Publicado: (2023)

Fatal ampicillin-sulbactam anaphylaxis in a 34-year-old male
por: Young, Marielle C., et al.
Publicado: (2023)

The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
por: de Oliveira, Maura S., et al.
Publicado: (2013)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Acinetobacter baumannii
por: Onita, Tetsushu, et al.
Publicado: (2023)

Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial
por: Shafiekhani, Mojtaba, et al.
Publicado: (2020)

Bone Concentration of Ampicillin/Sulbactam: A Pilot Study in Patients with Osteonecrosis of the Jaw
por: Straub, Anton, et al.
Publicado: (2022)

Impact of Third-Generation Cephalosporin Resistance on Recurrence in Children with Febrile Urinary Tract Infections
por: Kim, Sin Young, et al.
Publicado: (2022)

Ampicillin/Sulbactam versus Cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study
por: Ziogos, Eleftherios, et al.
Publicado: (2010)

Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Madadi-Goli, Nahid, et al.
Publicado: (2017)

1317. Pharmacokinetics (PK) of Ampicillin-Sulbactam (SAM) during Orthotopic Liver Transplantation (OLT)
por: Lasko, Maxwell J, et al.
Publicado: (2020)

Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam
por: Straub, Anton, et al.
Publicado: (2022)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
por: Xin, Xiaojuan, et al.
Publicado: (2013)

Inpatient Treatment for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease: Ampicillin/Sulbactam Vs. Cefoxitin
por: Hemsell, David L., et al.
Publicado: (1993)

T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam
por: Catena, Fausto, et al.
Publicado: (2013)

Tackling Intrinsic Antibiotic Resistance in Serratia marcescens with a Combination of Ampicillin/Sulbactam and Phage SALSA
por: Weber, Lorenz, et al.
Publicado: (2020)

1461. Impact of the Ampicillin/Sulbactam Shortage on Antibiotic Prescribing and Clinical Outcomes for Adult Inpatients with Aspiration Pneumonia
por: Staicu, Mary L, et al.
Publicado: (2020)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

2570. The intraoperative pharmacokinetics of ampicillin and sulbactam and the effect of massive bleeding in recipients of living donor liver transplantation
por: Wakimoto, Yuji, et al.
Publicado: (2023)

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria
por: Palombo, Marta, et al.
Publicado: (2023)

Comparing Treatment Outcomes of Ampicillin-Sulbactam, Other β-Lactams, and Vancomycin in Blood Culture-Negative Infective Endocarditis
por: Lee, Se Ju, et al.
Publicado: (2021)

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
por: Matthews, Peter, et al.
Publicado: (2012)

Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam
por: Miura, Makoto, et al.
Publicado: (2016)

Kounis syndrome presenting with acute inferior wall myocardial infarction and cardiogenic shock secondary to intravenous ampicillin/sulbactam administration
por: Keskin, Muhammed, et al.
Publicado: (2016)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

Comparison of Cefazolin/Metronidazole to Ampicillin/Sulbactam as Preoperative Antibiotics in Colorectal Surgery: A Retrospective, Single-Center Cohort Study
por: Im, Jae Hyoung, et al.
Publicado: (2023)

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)
por: Coccolini, Federico, et al.
Publicado: (2011)

The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study
por: Lai, Chih-Cheng, et al.
Publicado: (2019)

Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
por: Makris, Demosthenes, et al.
Publicado: (2018)

Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single‐center retrospective observational study
por: Suzuki, Tomokazu, et al.
Publicado: (2021)

Investigation of three common centrifugation protocols for platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam: a prospective trial
por: Straub, Anton, et al.
Publicado: (2023)

Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.
por: Noyes, N, et al.
Publicado: (1998)

Preparation and Evaluation of the ZnO NP–Ampicillin/Sulbactam Nanoantibiotic: Optimization of Formulation Variables Using RSM Coupled GA Method and Antibacterial Activities
por: Sharma, Nidhi, et al.
Publicado: (2019)

In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii
por: Gill, Christian M, et al.
Publicado: (2023)

Effect of Clindamycin compared with Ampicillin‐Sulbactam as prophylactic antibiotics for wound infections following major surgery for head and neck cancer: A meta‐analysis
por: Hu, Yue, et al.
Publicado: (2023)

In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole
por: Blondeau, Joseph M., et al.
Publicado: (2021)

1168. Role of Extended-Spectrum Cephalosporin-Resistance in Recurrent Enterobacteriaceae Urinary Tract Infections
por: Anesi, Judith, et al.
Publicado: (2018)

In Vitro Synergistic Effect of Curcumin in Combination with Third Generation Cephalosporins against Bacteria Associated with Infectious Diarrhea
por: Sasidharan, Nishanth Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dha6j8ravqdldbs2213vo93o4m